Clinical Trial Update: Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

View source ↗

Summary

Notes that the study NCT00908999, an fMRI investigation of anosognosia in amnestic mild cognitive impairment and Alzheimer's disease, has completed. The sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Anosognosia, Alzheimer's Disease | Status: COMPLETED